(Q24245590)

4

object named as

Martin Eccles

0 references

John R. Geddes

1

object named as

John Geddes

0 references

author name string

Nick Freemantle

2

0 references

J Boynton

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 July 2006

0 references

published in

0 references

cites work

Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

Comparative effects of fluoxetine and amitriptyline on cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

New or old antidepressants? New is better

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

New or old antidepressants? Benefits of new drugs are exaggerated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A general parametric approach to the meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Controlled comparison of nefazodone and amitriptyline in major depressive inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Moclobemide versus fluoxetine for a major depressive episode

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Fluvoxamine and chlorimipramine in endogenous depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A study comparing paroxetine placebo and imipramine in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Comparison of fluoxetine and desipramine in depressed outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Moclobemide versus fluoxetine for major depressive episodes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Moclobemide Versus Fluoxetine in the Treatment of Inpatients With Major Depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind multi-centre trial of fluoxetine and dothiepin in major depressive illness. South Wales Antidepressant Drug Trial Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A comparison of fluoxetine and amitriptyline in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Citalopram versus mianserin. A controlled, double-blind trial in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A comparison of the antidepressant action of citalopram and amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Nefazodone and imipramine in major depression: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Are SSRIs a cost-effective alternative to tricyclics?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021

Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001851.PUB2

7 January 2021